Affimed (NASDAQ: AFMD) last announced on 11 August the release of its quarterly earnings. The BIO posted earnings growth for a fourth quarter ($0.16), missing a forecast of ($0.12) calculated by ($0.04). Zacks published...
Read More
2 Minutes